CardioFocus Stock
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders.
Sign up today and learn more about CardioFocus Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About CardioFocus Stock
CardioFocus is a biotechnology company that focuses on the advancement of ablation treatments for cardiac disorders. The company specializes in providing electrophysiologists with innovative and effective tools that bring new levels of precision and control to the treatment of atrial fibrillation that focuses on developing, manufacturing, and investigating disposable fiber optic catheters for the visualization of the cardiac anatomy and the treatment of cardiac arrhythmias. CardioFocus was founded in 1990 and is headquartered in Marlborough, Massachusetts.
Funding History
August 1998 | $2.6M |
---|---|
January 2000 | $9.6M |
August 2001 | $1.8M |
June 2004 | $10.7M |
June 2008 | $9.1M |
June 2009 | $5.9M |
February 2011 | $30.6M |
March 2011 | $5.0M |
May 2013 | $11.0M |
May 2014 | $2.4M |
January 2015 | $32.0M |
May 2016 | $8.0M |
March 2017 | $20.2M |
June 2018 | $21.0M |
May 2019 | $55.0M |
July 2020 | $12.0M |
April 2022 | $4.0M |
Management
CEO & Board Member
Burke T Barrett
Executive Chairman
Paul LaViolette
VP Product Devlopment
Jerry Melsky
VP of Program Management
Rebecca Anderson
Bord of Directors
Michael Wasserman
VP of Operations
Mark Casey
Vice President of Operations
Brian K. Estabrook
Board of Directors
Bruce Robertson
Board Observer
Lisa Granick
Board Director
Paul LaViolette
Director, US Sales
Christopher F. Hallett
VP Sales & Marketing
Karl Firth
Press
bollyinside - Feb, 18 2024
CardioFocus Expands Electrophysiology Technology Division with Galvanize Therapeutics Acquisitioncardiacrhythmnews - Jan, 31 2024
Cardiac Rhythm News' top stories of 2023prnewswire - Jan, 15 2024
CardioFocus Acquires Electrophysiology Division of Galvanize Therapeuticsprnewswire - Dec, 21 2023
Pulsed Field Ablation Market to Exceed USD 5.4 billion by ...finance - Dec, 21 2023
Electrophysiology Devices Global Strategic Business Report ...